![[Translate to English:]](/typo3conf/ext/torr_template/Resources/Public/img/group-2021/placeholder-169.svg "[Translate to English:]")
- Total operating performance and revenue increased again
- Profit before tax at previous year’s level
- Net debt reduced compared with 1st half-year 2021/22
The PHOENIX group continued to grow in the first half of fiscal year 2022/23 (31 July 2022). The pan-European healthcare provider increased its revenue by 9.2 per cent, or €1.4 billion, to €16.2 billion, compared with the first half of 2021/22. Total operating performance rose by 10.0 per cent to €20.8 billion in comparison with the previous year. Total operating performance, which comprises revenue and handling for service charge, is the key figure relevant to pharmaceutical wholesale.
At €135.0 million, profit before tax was at the level of the previous year (€132.3 million). In the first half of 2021/22, costs related to inventory measurement in connection with the COVID-19 pandemic amounted to −€32.9 million. Adjusted for this one-off effect, profit before tax with €165.2 million was above the first half of 2022/23.
Robust key financial figures
“The PHOENIX group has achieved a solid first half of 2022/23, both in terms of revenue and results,” says Sven Seidel, Chief Executive Officer of PHOENIX Pharma SE, adding: “For the second half of the year, we anticipate continued challenges in areas such as transport and energy costs.”
Cautiously optimistic outlook for the year as a whole
Due to organic growth and acquisitions, the PHOENIX group expects to expand its market position in Europe in 2022/23. For the year as a whole, the company anticipates an increase in revenue slightly above the level of growth of the European pharmaceutical markets. Profit before tax is forecast to be at the level of 2021/22. PHOENIX expects a slight increase in the equity ratio.
Key figures of PHOENIX Pharma SE compared with the same period of the previous year
| 1st half-year 2021/22 in €m | 1st half-year 2022/23 in €m | |
Total operating performance1 | 18.942,9 | 20.831,1 |
Revenue | 14.816,2 | 16.178,6 |
EBITDA (before significant one-off effects) | 341,7 | 328,9 |
EBITDA | 308,8 | 328,9 |
EBIT | 167,0 | 182,7 |
Profit before tax (before significant one-off effects) | 165,2 | 135,0 |
Profit before tax | 132,3 | 135,0 |
Profit after tax | 98,5 | 98,6 |
Equity2 | 3.057,0 | 3.249,7 |
Equity ratio (in %)2 | 29,4 | 29,9 |
Net debt2 | 2.156,1 | 1.834,6 |
(Balance sheet date 31/07/2021)
1 Total operating performance = revenue + handled volume (handling for service charge).
2 As at reporting dates 31/07/2021 and 31/07/2022.
